# Evidence for Stuttering Treatment

Treatment for stuttering varies by age group, with the strongest evidence supporting behavioral speech therapy, particularly the Lidcombe Program for preschool children, and combined approaches addressing both speech fluency and psychosocial aspects for adolescents and adults.

## Preschool Children (Ages 2-6 Years)

The Lidcombe Program has the best evidence of efficacy for preschool children, with effect sizes ranging from Cohen's d = 0.72-1.00.[1] This parent-delivered intervention involves clinic visits where speech-language therapists teach parents how to conduct treatment at home, with the program typically taking one to two years to complete.[2] The Lidcombe Program results in lower stuttering frequency compared to wait-list controls and may increase speech efficiency.[2] Direct treatment approaches like the Lidcombe Program show faster reduction in stuttering during the first three months compared to indirect approaches, though outcomes are comparable at 18 months.[3]

Indirect treatment approaches also have strong evidence, focusing on modifying environmental demands and capacities rather than directly addressing the child's speech.[1] Early intervention is critical during the preschool years when brain plasticity is highest and before stuttering becomes persistent.[4][5]

## School-Age Children (Ages 6-12 Years)

There is limited solid evidence for any specific treatment in this age group.[1][6] One study showed that atomoxetine combined with speech therapy resulted in greater stuttering reduction compared to speech therapy alone in children, though this requires further investigation.[7] Syllable-timed speech (STS) treatment via the Westmead Program shows promise for school-age children: a laboratory study of four children (ages 8-11) found clinically significant stuttering reductions after Stage 1, with reduced variability in vowel duration confirming the rhythmic speech mechanism, while articulation rate and language complexity were not compromised.[31]

## Adolescents and Adults

Speech restructuring methods (fluency shaping) have good evidence with high effect sizes (Cohen's d = 0.75-1.63).[1] These techniques focus on modifying speech patterns to increase fluency.

Stuttering modification approaches have weaker evidence with intermediate effect sizes (Cohen's d = 0.56-0.65).[1] These methods teach individuals to stutter more easily rather than eliminate stuttering entirely.

A review of behavioral treatments confirms that speech restructuring therapy for adults has the most robust empirical evidence base, while stuttering management (anxiolytic) approaches lack strong treatment-effectiveness research but address critical dimensions like anxiety and avoidance.[26] Successful outcomes should measure not just stuttering frequency reduction but also "decreased anxiety associated with speaking, and improved social, educational, and occupational engagement."[26]

Evidence-based behavioral treatments that produce changes in timing and kind of speech motor patterns are currently the most effective treatments available for adults and are accompanied by substantial neural reorganization.[28] Two leading programs exemplify this:

**Kassel Stuttering Therapy (KST)** is an intensive, computer-aided fluency shaping program for teenagers and adults. It combines prolonged speech and soft voice onsets with cognitive-behavioral elements across an intensive 3-week inpatient phase, daily practice, and maintenance. Computer feedback helps participants monitor speech rate, breathing, and technique. Studies show significant stuttering reduction (e.g., 9.9% to 0.9% stuttering rate). Brain imaging research demonstrates that KST's fluency shaping techniques lead to increased activity in left-hemisphere speech areas, indicating neural reorganization.[28]

**Modifying Phonation Intervals (MPI)** uses biofeedback to train speakers to reduce short phonation intervals (under 100-150 ms) associated with stuttering, rather than prolonging speech. An accelerometer or electroglottograph sensor on the throat detects vocal fold vibration duration. The program progresses through establishment (in-clinic training), transfer (real-world application), and maintenance (self-monitored fluency). Over 65% of adult participants achieve successful treatment outcomes, producing more natural-sounding speech than traditional prolonged speech techniques.[28]

People who stutter may devote excessive attention to monitoring their own speech, limiting cognitive resources for other tasks. A preliminary study using a reading comprehension paradigm found that people who stutter had poorer comprehension when listening to their own speech, suggesting that excessive self-monitoring may exacerbate disfluency.[29] Self-disclosure of stuttering positively influences listener perceptions: speakers who disclosed their stuttering were rated as more friendly, outgoing, and confident compared to those who did not, while non-disclosing speakers were perceived as unfriendly and shy.[30] Disclosure also has quality-of-life benefits: adults who stutter and who disclose their stuttering report higher overall quality of life, including greater vitality and social functioning, compared to those who conceal it.[32]

Voluntary stuttering — intentionally stuttering on non-feared words — has been shown to suppress true stuttering events, providing evidence that the speech perception-production link plays a key role in stuttering dynamics. This supports stuttering modification techniques that use voluntary disfluency to reduce fear and avoidance.[36]

The theoretical relationship between stuttering and its treatment remains complex: multiple theoretical frameworks (motor control, linguistic, psychological) each explain some aspects of stuttering but no single theory accounts for all phenomena, which supports multidimensional treatment approaches that address motor, linguistic, and psychological factors simultaneously.[34]

Integrated approaches combining fluency techniques with psychological interventions show promise. The Multidimensional Individualized Stuttering Therapy (MIST), which combines Acceptance and Commitment Therapy (ACT) with speech modification, demonstrates significant reduction in stuttering impact with moderate to very large effect sizes.[8] Similarly, the fACTS Program integrating fluency training with ACT shows improvements in self-efficacy, psychosocial functioning, and speech fluency.[9] The neuroscience of affect labeling supports ACT-based strategies: fMRI research demonstrates that putting feelings into words ("I'm noticing anxiety about speaking") disrupts amygdala activity, providing a neural mechanism for why cognitive defusion and emotional labeling reduce anxiety in stuttering contexts.[33]

Slow, controlled breathing has well-documented psycho-physiological effects including reduced anxiety, increased parasympathetic tone, and improved emotional regulation.[35] Progressive muscle relaxation (PMR) — systematically tensing and releasing muscle groups combined with breathing exercises — is a complementary technique with strong meta-analytic evidence for reducing anxiety (SMD = -1.32) and improving quality of life in clinical populations.[37] While breathing regulation alone is not recommended as a stuttering treatment,[1] controlled breathing and muscle relaxation as components of comprehensive approaches (e.g., panic management, pre-speaking calming) have evidence-based benefits for anxiety reduction that accompanies stuttering.

## Pharmacological Treatment

Newer antipsychotics show promising results with better tolerability than conventional antipsychotics, though evidence remains limited.[7] Risperidone has been shown more effective than placebo in decreasing stuttering severity (Cohen's d = 0.84).[10][27] Olanzapine demonstrated a 22% reduction on subjective stuttering scales versus <1% for placebo, though associated with approximately 4 kg average weight gain.[27] Dopamine antagonist medications are effective in reducing stuttering severity, with second-generation antipsychotics showing better tolerability than first-generation agents; emerging research points to selective D1 antagonists and VMAT-2 inhibitors as novel treatment mechanisms.[27] However, no FDA-approved medication currently exists for stuttering, and pharmacotherapy is not supported as a sole or main treatment based on current evidence.[1][27] Side effects vary widely, and conventional antipsychotics may cause severe adverse effects leading to treatment withdrawal.[7]

## Not Recommended

Evidence does not support rhythmic speaking, breathing regulation as sole treatment, hypnosis, or eclectic unspecified therapies.[1]

## References

1. The Pathogenesis, Assessment and Treatment of Speech Fluency Disorders. Neumann K, Euler HA, Bosshardt HG, et al. *Deutsches Arzteblatt International*. 2017;114(22-23):383-390. doi:10.3238/arztebl.2017.0383.
2. Non-Pharmacological Interventions for Stuttering in Children Six Years and Younger. Sjostrand A, Kefalianos E, Hofslundsengen H, et al. *The Cochrane Database of Systematic Reviews*. 2021;9:CD013489. doi:10.1002/14651858.CD013489.pub2.
3. Direct Versus Indirect Treatment for Preschool Children Who Stutter: The RESTART Randomized Trial. de Sonneville-Koedoot C, Stolk E, Rietveld T, Franken MC. *PloS One*. 2015;10(7):e0133758. doi:10.1371/journal.pone.0133758.
4. Treatment for Preschool Age Children Who Stutter: Protocol of a Randomised, Non-Inferiority Parallel Group Pragmatic Trial With Mini-Kids, Social Cognitive Behaviour Treatment and the Lidcombe Program-TreatPaCS. Leclercq AL, Waelkens V, Roelant E, et al. *PloS One*. 2024;19(7):e0304212. doi:10.1371/journal.pone.0304212.
5. Stuttering: Clinical and Research Update. Perez HR, Stoeckle JH. *Canadian Family Physician Medecin De Famille Canadien*. 2016;62(6):479-84.
6. Stuttering Interventions for Children, Adolescents, and Adults: A Systematic Review as a Part of Clinical Guidelines. Laiho A, Elovaara H, Kaisamatti K, et al. *Journal of Communication Disorders*. 2022 Sep-Oct;99:106242. doi:10.1016/j.jcomdis.2022.106242.
7. Pharmacological and Dietary Treatments for Developmental Stuttering: A Systematic Review. Horton S, Forbes EJ, Scheffer I, et al. *Neuroscience and Biobehavioral Reviews*. 2025;:106427. doi:10.1016/j.neubiorev.2025.106427.
8. What Works for Whom? Multidimensional Individualized Stuttering Therapy (MIST). Sonsterud H, Halvorsen MS, Feragen KB, Kirmess M, Ward D. *Journal of Communication Disorders*. 2020 Nov-Dec;88:106052. doi:10.1016/j.jcomdis.2020.106052.
9. Evaluation of an Integrated Fluency and Acceptance and Commitment Therapy Intervention for Adolescents and Adults Who Stutter. Hart AK, Breen LJ, Hennessey NW, Beilby JM. *Journal of Speech, Language, and Hearing Research*. 2024;67(4):1003-1019. doi:10.1044/2023_JSLHR-23-00252.
10. Stuttering: An Update for Physicians. Costa D, Kroll R. *CMAJ: Canadian Medical Association Journal*. 2000;162(13):1849-55.
11. Stuttering Inhibition via Altered Auditory Feedback During Scripted Telephone Conversations. Hudock D, Kalinowski J. *International Journal of Language & Communication Disorders*. 2014 Jan-Feb;49(1):139-47. doi:10.1111/1460-6984.12053.
12. Effect of Monaural and Binaural Altered Auditory Feedback on Stuttering Frequency. Stuart A, Kalinowski J, Rastatter MP. *The Journal of the Acoustical Society of America*. 1997;101(6):3806-9. doi:10.1121/1.418387.
13. An Experimental Investigation of the Effect of Altered Auditory Feedback on the Conversational Speech of Adults Who Stutter. Lincoln M, Packman A, Onslow M, Jones M. *Journal of Speech, Language, and Hearing Research*. 2010;53(5):1122-31. doi:10.1044/1092-4388(2009/07-0266).
14. Effect of Delayed Auditory Feedback on Stuttering-Like Disfluencies. Alqhazo M, Alkhamaiseh Z. *International Journal of Language & Communication Disorders*. 2025 Mar-Apr;60(2):e70007. doi:10.1111/1460-6984.70007.
15. Supplementing Stuttering Treatment With Online Cognitive Behavior Therapy: An Experimental Trial. Menzies R, O'Brian S, Packman A, et al. *Journal of Communication Disorders*. 2019 Jul-Aug;80:81-91. doi:10.1016/j.jcomdis.2019.04.003.
16. In-Clinic and Standalone Internet Cognitive Behavior Therapy Treatment for Social Anxiety in Stuttering: A Randomized Trial of iGlebe. Menzies RG, Packman A, Onslow M, et al. *Journal of Speech, Language, and Hearing Research*. 2019;62(6):1614-1624. doi:10.1044/2019_JSLHR-S-18-0340.
17. Randomised Controlled Trial of the Lidcombe Programme of Early Stuttering Intervention. Jones M, Onslow M, Packman A, et al. *BMJ (Clinical Research Ed.)*. 2005;331(7518):659. doi:10.1136/bmj.38520.451840.E0.
18. Effectiveness of Stuttering Modification Treatment in School-Age Children Who Stutter: A Randomized Clinical Trial. Kohmascher A, Primassin A, Heiler S, et al. *Journal of Speech, Language, and Hearing Research*. 2023;66(11):4191-4205. doi:10.1044/2023_JSLHR-23-00224.
19. Screening for Speech and Language Delay and Disorders in Children 5 Years or Younger: Evidence Report and Systematic Review for the US Preventive Services Task Force. Feltner C, Wallace IF, Nowell SW, et al. *JAMA*. 2024;331(4):335-351. doi:10.1001/jama.2023.24647.
20. Stuttering in Preschool Children: Direct Versus Indirect Treatment. Nippold MA. *Language, Speech, and Hearing Services in Schools*. 2018;49(1):4-12. doi:10.1044/2017_LSHSS-17-0066.
21. Non-Pharmacological Treatments for Stuttering in Children and Adults: A Systematic Review and Evaluation of Clinical Effectiveness, and Exploration of Barriers to Successful Outcomes. Baxter S, Johnson M, Blank L, et al. *Health Technology Assessment (Winchester, England)*. 2016;20(2):1-302, v-vi. doi:10.3310/hta20020.
22. Stuttering Treatment Research 1970-2005: I. Systematic Review Incorporating Trial Quality Assessment of Behavioral, Cognitive, and Related Approaches. Bothe AK, Davidow JH, Bramlett RE, Ingham RJ. *American Journal of Speech-Language Pathology*. 2006;15(4):321-41. doi:10.1044/1058-0360(2006/031).
23. The State of the Art in Non-Pharmacological Interventions for Developmental Stuttering. Part 1: A Systematic Review of Effectiveness. Baxter S, Johnson M, Blank L, et al. *International Journal of Language & Communication Disorders*. 2015 Sep-Oct;50(5):676-718. doi:10.1111/1460-6984.12171.
24. Defining, Identifying, and Evaluating Clinical Trials of Stuttering Treatments: A Tutorial for Clinicians. Onslow M, Jones M, O'Brian S, Menzies R, Packman A. *American Journal of Speech-Language Pathology*. 2008;17(4):401-15. doi:10.1044/1058-0360(2008/07-0047).
25. Selecting Treatments and Monitoring Outcomes: The Circle of Evidence-Based Practice and Client-Centered Care in Treating a Preschool Child Who Stutters. Bernstein Ratner N. *Language, Speech, and Hearing Services in Schools*. 2018;49(1):13-22. doi:10.1044/2017_LSHSS-17-0015.
26. Behavioral Treatments for Children and Adults Who Stutter: A Review. Blomgren M. *Psychology Research and Behavior Management*. 2013;6:9-19. doi:10.2147/PRBM.S31450.
27. The Pharmacologic Treatment of Stuttering and Its Neuropharmacologic Basis. Maguire GA, Nguyen DL, Simonson KC, Kurz TL. *Frontiers in Neuroscience*. 2020;14:158. doi:10.3389/fnins.2020.00158.
28. Stuttering Treatment and Brain Research in Adults: A Still Unfolding Relationship. Ingham RJ, Ingham JC, Euler HA, Neumann K. *Journal of Fluency Disorders*. 2018;55:106-119. doi:10.1016/j.jfludis.2017.02.003.
29. Does Excessive Attention to Speech Contribute to Stuttering? A Preliminary Study With a Reading Comprehension Task. Iimura D, Uehara S, Yamamoto S, Aihara T, Kushiro K. *Perspectives of the ASHA Special Interest Groups*. 2016;1(4):5-15. doi:10.1044/persp1.SIG4.5.
30. The Effects of Self-Disclosure on Male and Female Perceptions of Individuals Who Stutter. Byrd CT, McGill M, Gkalitsiou Z, Cappellini C. *American Journal of Speech-Language Pathology*. 2017;26(1):69-80. doi:10.1044/2016_AJSLP-15-0164.
31. Conversational Speech of School-Age Children After Syllable-Timed Speech Treatment for Stuttering. Brown L, Wilson L, Packman A, Halaki M, Andrews C, O'Brian S, Onslow M, Menzies RG. *International Journal of Speech-Language Pathology*. 2022;24(1):42-52. doi:10.1080/17549507.2021.1946152.
32. Disclosure of Stuttering and Quality of Life in People Who Stutter. Boyle MP, Milewski KM, Beita-Ell C. *Journal of Fluency Disorders*. 2018;58:1-10. doi:10.1016/j.jfludis.2018.10.003.
33. Putting Feelings Into Words: Affect Labeling Disrupts Amygdala Activity in Response to Affective Stimuli. Lieberman MD, Eisenberger NI, Crockett MJ, Tom SM, Pfeifer JH, Way BM. *Psychological Science*. 2007;18(5):421-428. doi:10.1111/j.1467-9280.2007.01916.x.
34. Theory and Therapy in Stuttering: A Complex Relationship. Packman A. *Journal of Fluency Disorders*. 2012;37(4):225-233. doi:10.1016/j.jfludis.2012.05.004.
35. How Breath-Control Can Change Your Life: A Systematic Review on Psycho-Physiological Correlates of Slow Breathing. Zaccaro A, Piarulli A, Laurino M, Garbella E, Menicucci D, Neri B, Gemignani A. *Frontiers in Human Neuroscience*. 2018;12:353. doi:10.3389/fnhum.2018.00353.
36. Voluntary Stuttering Suppresses True Stuttering: A Window on the Speech Perception-Production Link. Saltuklaroglu T, Kalinowski J, Guntupalli VK. *Perception & Psychophysics*. 2004;66(2):249-254. doi:10.3758/BF03194876.
37. Effects of Progressive Muscle Relaxation on Health-Related Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Tan L, Fang P, Cui J, Yu H, Yu L. *Complementary Therapies in Clinical Practice*. 2022;49:101676. doi:10.1016/j.ctcp.2022.101676.
